Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions

In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 (COVID-19) is marked by aberrant innate and adaptive immune responses with an abnormal cytokine profile and multiorgan system dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyerowitz, Eric A, Sen, Pritha, Schoenfeld, Sara R, Neilan, Tomas G, Frigault, Matthew J, Stone, John H, Kim, Arthur Y, Mansour, Michael K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717185/
https://www.ncbi.nlm.nih.gov/pubmed/33216852
http://dx.doi.org/10.1093/cid/ciaa1759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717185/
https://www.ncbi.nlm.nih.gov/pubmed/33216852
http://dx.doi.org/10.1093/cid/ciaa1759

Ejemplares similares